How were Keryx Biopharmaceuticals' earnings last quarter?
Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) issued its quarterly earnings results on Thursday, November, 8th. The biopharmaceutical company report...
Who are Keryx Biopharmaceuticals' key executives?
Keryx Biopharmaceuticals' management team includes the following people: Ms. Jodie Pope Morrison , Interim CEO & Director (Age 43) Mr. Scott A....
Who are some of Keryx Biopharmaceuticals' key competitors?
Some companies that are related to Keryx Biopharmaceuticals include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Reg...
What other stocks do shareholders of Keryx Biopharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Keryx Biopharmaceuticals investors own include Synergy Pha...
What is Keryx Biopharmaceuticals' stock symbol?
Keryx Biopharmaceuticals trades on the NASDAQ under the ticker symbol "KERX."
What is Keryx Biopharmaceuticals' stock price today?
One share of KERX stock can currently be purchased for approximately $3.36.
How much money does Keryx Biopharmaceuticals make?
Keryx Biopharmaceuticals (NASDAQ:KERX) has a market capitalization of $344.00 million and generates $60.64 million in revenue each year. The biopha...
What is Keryx Biopharmaceuticals' official website?
The official website for Keryx Biopharmaceuticals is www.keryx.com .
How can I contact Keryx Biopharmaceuticals?
Keryx Biopharmaceuticals' mailing address is ONE MARINA PARK DR., BOSTON MA, 02210 . The biopharmaceutical company can be reached via phone at 61...
How much does Keryx make?
What is Keryx Biopharmaceuticals' stock symbol?
How much money does Keryx Biopharmaceuticals make? Keryx Biopharmaceuticals has a market capitalization of $344.00 million and generates $60.64 million in revenue each year. The biopharmaceutical company earns $-163,440,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis.
What other stocks do shareholders of Keryx Biopharmaceuticals own?
Keryx Biopharmaceuticals trades on the NASDAQ under the ticker symbol "KERX ."
Where are Keryx Biopharmaceuticals' headquarters?
Based on aggregate information from My MarketBeat watchlists, some companies that other Keryx Biopharmaceuticals investors own include Synergy Pharmaceuticals (SGYP), Amyris (AMRS), Gilead Sciences (GILD), Exelixis (EXEL), Immunomedics (IMMU), Novavax (NVAX), Akebia Therapeutics (AKBA), Ariad Pharmaceuticals (ARIA), Chesapeake Energy (CHKAQ) and Celldex Therapeutics (CLDX).
What is the P/E ratio of Keryx?
Keryx Biopharmaceuticals is headquartered at ONE MARINA PARK DR., BOSTON MA, 02210.
Does Keryx pay dividends?
The P/E ratio of Keryx Biopharmaceuticals is -3.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
What is the KEX symbol?
Keryx Biopharmaceuticals does not currently pay a dividend.
What is Kirby Corp?
Kirby trades on the New York Stock Exchange (NYSE) under the ticker symbol "KEX."
What is the rating of Kirby?
Kirby Corp. engages in the provision of diesel engines, reduction gears and ancillary products for marine and power generation applications. It operates through the following segments: Marine Transportation and Distribution & Services segment. The Marine Transportation segment provides marine transportation services, operates tank barges and towing vessels transporting bulk liquid products and transports petrochemicals, refined petroleum products, black oil products and agricultural chemicals by tank barge. The Distribution & Services segment sells genuine replacement parts, provides service mechanics to overhaul and repair medium-speed and high-speed diesel engines, transmissions, reduction gears, pumps and compression products, maintains facilities to rebuild component parts or entire medium-speed and high-speed diesel engines, transmissions and reduction gears and manufactures and remanufactures oilfield service equipment, including pressure pumping units. The company was founded in 1921 and is headquartered in Houston, TX.
How many hold ratings are there for Kirby?
Kirby has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.
Does Kirby pay dividends?
There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Kirby stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KEX, but not buy additional shares or sell existing shares.
When will Kirby announce its second quarter results?
Kirby does not currently pay a dividend.
When is Kirby's earnings call 2021?
Central Daylight Time (“CDT”) on Thursday, July 29, 2021. This announcement will be followed by an earnings conference call webcast at 7:30 a.m. CDT. To listen to the webcast, please visit the Investor Relations section of Kirby’s website at www.kirbycorp.com. For listeners who wish to participate in the question and answer session of the webcast, you may
What is Kirby's adjusted EBITDA?
NEW YORK, NY / ACCESSWIRE / April 29, 2021 / Kirby Corp. (NYSE:KEX) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 29, 2021 at 8:30 AM Eastern Time.
Where is Kirby Corporation located?
Adjusted EBITDA is one of the performance measures used in Kirby’s incentive bonus plan. Adjusted EBITDA is also used by rating agencies in determining Kirby’s credit rating and by analysts publishing research reports on Kirby, as well as by investors and investment bankers generally in valuing companies.
Is Kirby's cost management efforts encouraging?
About Kirby Corporation Kirby Corporation, based in Houston, Texas, is the nation’s largest domestic tank barge operator transporting bulk liquid products throughout the Mississippi River System, on the Gulf Intracoastal Waterway, coastwise along all three United States coasts, and in Alaska and Hawaii.
Is Kirby a KEX?
Kirby's (KEX) cost-management efforts are encouraging. Weakness in the coastal market and dismal cash position are a headwind.
